Letter: hepatocellular carcinoma surveillance determines survival in patients at risk
Aliment Pharmacol Ther
.
2019 Oct;50(7):839-840.
doi: 10.1111/apt.15461.
Authors
Shao-Liang Zhu
1
,
Yuan-Qi Li
1
,
Hui Hu
1
,
Liang Ma
1
Affiliation
1
Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital.
PMID:
31532553
DOI:
10.1111/apt.15461
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Carcinoma, Hepatocellular*
Hepatitis B*
Humans
Liver Cirrhosis
Liver Neoplasms*
Grants and funding
GXMUYSF201302/Youth Science Foundation of Guangxi Medical University/International
2018GXNSFAA050124/Guangxi Natural Science Foundation/International
YJSA2017014/Graduate Course Construction Project of Guangxi Medical University/International